BlackRock Health Sciences Trust (NYSE:BME) to Issue $0.26 Monthly Dividend

BlackRock Health Sciences Trust (NYSE:BME) declared a monthly dividend on Monday, November 3rd. Stockholders of record on Friday, November 14th will be given a dividend of 0.2621 per share on Friday, November 28th. This represents a c) annualized dividend and a dividend yield of 8.2%. The ex-dividend date is Friday, November 14th.

BlackRock Health Sciences Trust Trading Down 0.5%

NYSE:BME opened at $38.18 on Tuesday. The company has a fifty day moving average of $37.29 and a 200-day moving average of $36.57. BlackRock Health Sciences Trust has a twelve month low of $34.18 and a twelve month high of $41.36.

Institutional Trading of BlackRock Health Sciences Trust

Hedge funds have recently modified their holdings of the stock. Comerica Bank grew its position in BlackRock Health Sciences Trust by 7.9% in the 1st quarter. Comerica Bank now owns 4,807 shares of the company’s stock valued at $186,000 after purchasing an additional 353 shares during the period. SOA Wealth Advisors LLC. grew its position in BlackRock Health Sciences Trust by 20.3% in the 3rd quarter. SOA Wealth Advisors LLC. now owns 2,780 shares of the company’s stock valued at $103,000 after purchasing an additional 469 shares during the period. Stratos Wealth Partners LTD. grew its position in BlackRock Health Sciences Trust by 7.9% in the 1st quarter. Stratos Wealth Partners LTD. now owns 7,037 shares of the company’s stock valued at $272,000 after purchasing an additional 517 shares during the period. Cetera Investment Advisers grew its position in BlackRock Health Sciences Trust by 4.6% in the 1st quarter. Cetera Investment Advisers now owns 12,414 shares of the company’s stock valued at $480,000 after purchasing an additional 546 shares during the period. Finally, Royal Bank of Canada grew its position in BlackRock Health Sciences Trust by 0.5% in the 1st quarter. Royal Bank of Canada now owns 143,546 shares of the company’s stock valued at $5,546,000 after purchasing an additional 684 shares during the period.

About BlackRock Health Sciences Trust

BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services.